Bristol-Myers Squibb Co (NYSE: BMY): The Best-Of-Breed For Investing?
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 7.88% and 21.93% over the past three months. BMY shares are trading 16.59% year to date (YTD), with the 12-month market performance up to 18.67% higher. […]
Bristol-Myers Squibb Co (NYSE: BMY): Hunting Genuine Value In Market Debris
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 4.62% and 14.14% over the past three months. BMY shares are trading 5.87% year to date (YTD), with the 12-month market performance up to 5.93% higher. […]
Reviewing The Case For Bristol-Myers Squibb Co. (BMY) Going Higher
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 1.00% and 7.32% over the past three months. BMY shares are trading 2.59% year to date (YTD), with the 12-month market performance down to -0.62% lower. […]
Why Should You Put Bristol-Myers Squibb Co. (NYSE: BMY) On Your Portfolio?
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 0.00% and 18.14% over the past three months. BMY shares are trading 2.83% year to date (YTD), with the 12-month market performance down to -6.55% lower. […]
Uncovering Institutional Buying In Bristol-Myers Squibb Co. (NYSE: BMY)
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -1.44% and 27.84% over the past three months. BMY shares are trading 2.65% year to date (YTD), with the 12-month market performance down to -6.38% lower. […]
Bristol-Myers Squibb Co. (BMY): Street Finally Waking Up
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 5.99% and 34.93% over the past three months. BMY shares are trading 5.16% year to date (YTD), with the 12-month market performance down to -4.88% lower. […]
Is Bristol-Myers Squibb Co. (NYSE: BMY) Back In The Buying Zone?
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 3.04% and 22.59% over the past three months. BMY shares are trading -0.78% year to date (YTD), with the 12-month market performance down to -12.06% lower. […]
Bristol-Myers Squibb Co. (BMY): Street Finally Waking Up
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 0.57% and 17.84% over the past three months. BMY shares are trading -3.70% year to date (YTD), with the 12-month market performance down to -15.94% lower. […]
Bristol-Myers Squibb Co. (BMY): Street Finally Waking Up
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Why Should You Put Bristol-Myers Squibb Co. (NYSE: BMY) On Your Portfolio?
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
